Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.
Researchers confirm plasma pTau181 is a strong predictor for Alzheimer’s in patients with mild cognitive impairment, offering a less invasive diagnostic tool for early intervention.